This morning, I saw the reference to this study and looked it up. Frankly, most of it is over my head, but I have some questions about it.
1. Study size was 20 unvaxxed and 7 vaxxed. Isn't that too small to provide reliable results? I didn't see any prominently mentioned P values, but maybe I missed them... no coffee yet his morning.
2. The scatter chart of the vaxxed showed two outliers at the top. Obviously, they skewed the outcome a little.
3. As mentioned in the limitations, blood tests were done early in treatment and antibody levels might not have peaked.
4. Antibody levels at early infection aren't necessarily predictive of what they will be six months from now.
4. We know the vaccines work, greatly reducing the risk of getting Covid, but it didn't work for these 7 breakthrough. Thus, they are a nonrandom selection of the vaccinated population. For some reason, they got Covid again while the majority of their vaccinated peers did not.
tl;dr
It appears that low responders to the vaccine who get Omicron will have higher resistance to future Covid than nonvaxxed who get Omicron.
It would be nice to see a followup study in six months or so, assuming those 7 don't get boosted again in the interim period.